Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 2 of 2 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GABAPENTINA | 1件: Gabapentin Gabapentin (Gabapentina) | 1件: Gabapentin
Gabapentin
💬1. GABAPENTINA
| 5件: CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 1. GABAPENTINA
| 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac ... | 1件: 6 6 💬1. GABAPENTINA
| ||||||||||||||||||||||
| 2 | GABAPENTINA KERN PHARMA | 1件: Gabapentin Gabapentin (Gabapentina) | 1件: Gabapentin
Gabapentin
💬2. GABAPENTINA KERN PHARMA
| 5件: CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 2. GABAPENTINA KERN PHARMA
| 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac ... | 1件: 6 6 💬2. GABAPENTINA KERN PHARMA
|